Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Best match
Most recent
PipelineReview.com
4h
U.S. FDA Approves Pfizer’s HYMPAVZI™ (marstacimab-hncq) for the Treatment of Adults and Adolescents with Hemophilia A or B Without Inhibitors
NEW YORK, NY, USA I October 11, 2024 I Pfizer Inc. (NYSE: PFE)announced today that the U.S. Food and Drug Administration (FDA) has approved HYMPAVZIâ„¢ ...
PipelineReview.com
4h
US FDA Approves Dong-A ST’s IMULDOSAâ„¢ (ustekinumab-srlf), a Biosimilar to STELARA®
Dong-A ST’s biologics license application (BLA) for Imuldosa, submitted in October 2023, is approved by the U.S. Food and Drug Administration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Oklahoma mass shooting
How to help Milton victims
Requests military aircraft
Man attacked, killed by dogs
Gators displaced by Milton
Gets Walk of Fame star
Loses bid to get on PA ballot
Gets 2 years for role in riot
To close 444 stores
Mr. Bungle ex-member guilty
Russia cements ties with Iran
S&P 500, Dow hit records
CA rejects SpaceX plan
Expands sanctions on Iran
Admonishes Black men
JPMorgan says soft landing
Drownings were avoidable?
Meningitis outbreak sentence
Files suit against Virginia
Carne asada drug bust
Calls for relief funding
Dodgers advance to NLCS
US consumer sentiment slips
Indicted on 6 felony counts
Adds 8 new destinations
Assets hit $11.5 trillion
US producer prices flat
To cut workforce by 10%
Drug for hemophilia approved
Fidelity data breach
FTX exec heads to prison
Feedback